These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17516154)
1. Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats. Taniguchi H; Kojima R; Sade H; Furuya M; Inomata N; Ito M J Clin Immunol; 2007 Jul; 27(4):409-29. PubMed ID: 17516154 [TBL] [Abstract][Full Text] [Related]
2. Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats. Fujinaka H; Yamamoto T; Takeya M; Feng L; Kawasaki K; Yaoita E; Kondo D; Wilson CB; Uchiyama M; Kihara I J Am Soc Nephrol; 1997 Jul; 8(7):1174-8. PubMed ID: 9219168 [TBL] [Abstract][Full Text] [Related]
3. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555 [TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat. Reynolds J; Cook PR; Behmoaras J; Smith J; Bhangal G; Tadros S; Tee J; Salama AD; Evans DJ; Aitman TJ; Cook HT; Pusey CD Am J Pathol; 2012 May; 180(5):1843-51. PubMed ID: 22445570 [TBL] [Abstract][Full Text] [Related]
5. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis. Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Kanaguchi Y; Suzuki Y; Osaki K; Sugaya T; Horikoshi S; Tomino Y Nephrol Dial Transplant; 2011 Nov; 26(11):3465-73. PubMed ID: 21525165 [TBL] [Abstract][Full Text] [Related]
7. Tubulointerstitial injury of Thy-1 nephritis in uninephrectomized stroke-prone spontaneously hypertensive rats. Wang PR; Masuda Y; Kitamura H; Yamanaka N J Nippon Med Sch; 2001 Aug; 68(4):301-9. PubMed ID: 11505277 [TBL] [Abstract][Full Text] [Related]
8. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis. Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1043-53. PubMed ID: 23408165 [TBL] [Abstract][Full Text] [Related]
9. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028 [TBL] [Abstract][Full Text] [Related]
10. Differentiating Glomerular Inflammation from Fibrosis in a Bone Marrow Chimera for Rat Anti-Glomerular Basement Membrane Glomerulonephritis. Zhou C; Lou K; Tatum K; Funk J; Wu J; Bartkowiak T; Kagan D; Lou Y Am J Nephrol; 2015; 42(1):42-53. PubMed ID: 26337665 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142 [TBL] [Abstract][Full Text] [Related]
13. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). Wada T; Yokoyama H; Furuichi K; Kobayashi KI; Harada K; Naruto M; Su SB; Akiyama M; Mukaida N; Matsushima K FASEB J; 1996 Oct; 10(12):1418-25. PubMed ID: 8903512 [TBL] [Abstract][Full Text] [Related]
14. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. Reynolds J; Pusey CD J Am Soc Nephrol; 2001 Jan; 12(1):61-70. PubMed ID: 11134251 [TBL] [Abstract][Full Text] [Related]
15. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis. Iyoda M; Shibata T; Wada Y; Kuno Y; Shindo-Hirai Y; Matsumoto K; Akizawa T Nephrol Dial Transplant; 2013 Mar; 28(3):576-84. PubMed ID: 23045430 [TBL] [Abstract][Full Text] [Related]
16. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis. Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978 [TBL] [Abstract][Full Text] [Related]
17. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat. Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913 [TBL] [Abstract][Full Text] [Related]
18. FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats. Ni HF; Chen JF; Zhang MH; Pan MM; Zhang JD; Liu H; Tang RN; Ma KL; Liu BC Ren Fail; 2013 Aug; 35(7):996-1004. PubMed ID: 23848241 [TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Panzer U; Thaiss F; Zahner G; Barth P; Reszka M; Reinking RR; Wolf G; Helmchen U; Stahl RA Kidney Int; 2001 May; 59(5):1762-9. PubMed ID: 11318946 [TBL] [Abstract][Full Text] [Related]
20. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. Zhou A; Ueno H; Shimomura M; Tanaka R; Shirakawa T; Nakamura H; Matsuo M; Iijima K Kidney Int; 2003 Jul; 64(1):92-101. PubMed ID: 12787399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]